Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

32

Revenue 2017

Truvada

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Truvada was produced by Gilead Sciences.

ViiV starts trial of HIV-preventing injections for women

ViiV starts trial of HIV-preventing injections for women

can defend against the spread of the virus as well as daily dosing with Gilead’s oral pre-exposure prophylaxis (PrEP) therapy Truvada (emtricitabine and tenofovir disoproxil).

People at-risk of HIV in England could get PrEP from September

People at-risk of HIV in England could get PrEP from September The study of Gilead's pre-exposure prophylaxis (PrEP) therapy Truvada (emtricitabine and tenofovir disoproxil) - which was approved by the EMA last year - follows a pilot that saw the drug prevent ... The cost of the generic is unknown, but Truvada's UK

Gilead plans fightback against HIV arch-rival ViiV

Gilead plans fightback against HIV arch-rival ViiV The drug is an upgrade to Truvada, which combined emtricitabine with an older and less potent tenofovir salt (tenofovir disoproxil fumarate) that is heading for patent expiry.

Gilead's Truvada cleared for HIV prevention in EU

Gilead's Truvada cleared for HIV prevention in EU Gilead's Truvada cleared for HIV prevention in EU. May help slow down recent uptick in new HIV diagnoses. ... This is encouraging, as we know Truvada has an important role to play as part of comprehensive HIV prevention for many at-risk individuals," he

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics